Biosynex and Chembio Diagnostics Announce Definitive Acquisition Agreement
GlobeNewswire
Complementary Technologies, Product Portfolios, and Market Opportunities Expected to Represent Significant Growth..
Complementary Technologies, Product Portfolios, and Market Opportunities Expected to Represent Significant Growth..
*A**pproximately 60% of patients aged 12 years and older** treated with Dupixent 300 mg weekly in the pivotal trial experienced..
Israel's president met with the President of the European Commission Ursula von der Leyen in a closed meeting on Wednesday.